Photodynamic therapy in the treatment of basal cell carcinoma: A systematic review and meta-analysis

Photodermatology Photoimmunology and Photomedicine

Volumn 31, Issue 1, 2015, Pages 44-53

  Wang, Hongfei ^a   Xu, Yuanyuan ^a   Shi, Jingpu ^a   Gao, Xinghua ^a   Geng, Long ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Basal cell carcinoma; Meta analysis; Photodynamic therapy

Indexed keywords

COSMETIC; FLUOROURACIL; IMIQUIMOD; PHOTOSENSITIZING AGENT; PLACEBO; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC ANTIMETABOLITE;

ARTICLE; BASAL CELL CARCINOMA; BIBLIOGRAPHIC DATABASE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER SURGERY; CLEARANCE; COMPARATIVE EFFECTIVENESS; CRYOTHERAPY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ERYTHEMA; ESTHETICS; EVIDENCE BASED PRACTICE; EXCISION; HUMAN; INTERVENTION STUDY; LIGHT DAMAGE; META ANALYSIS; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; SKIN BLEEDING; SKIN BURNING SENSATION; SKIN DISCOMFORT; SKIN PRURITUS; SYSTEMATIC REVIEW; TOPICAL TREATMENT; TREATMENT OUTCOME; CARCINOMA, BASAL CELL; COMPARATIVE STUDY; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; SKIN NEOPLASMS; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, BASAL CELL; FLUOROURACIL; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS; TIME FACTORS;

EID: 84920941661     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/phpp.12148     Document Type: Article

References (33)

1. Leman JA, McHenry PM. Basal cell carcinoma: still an enigma. Arch Dermatol 2001; 137: 1239-1240.
2. Aguayo-Leiva IR, Rios-Buceta L, Jaen-Olasolo P. Surgical vs nonsurgical treatment of basal cell carcinoma. Actas Dermosifiliogr 2010; 101: 683-692.
3. Jung GW, Metelitsa AI, Dover DC, Salopek TG. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007. Br J Dermatol 2010; 163: 146-154.
4. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J Invest Dermatol 1994; 102: 4S-5S.
5. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007; 24: CD003412.
6. Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006; 45: 489-498.
7. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207-214.
8. Peng Q, Warloe T, Berg K etal. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-2308.
9. Foley P, Freeman M, Menter A etal. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol 2009; 48: 1236-1245.
10. Jadad AR, Moore RA, Carroll D etal. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
11. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982-989.
12. Moher D, Pham B, Jones A etal. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Roozeboom MH, Aardoom MA, Nelemans PJ etal. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol 2013; 69: 280-287.
16. Arits AH, Mosterd K, Essers BA etal. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013; 14: 647-654.
17. Szeimies RM, Ibbotson S, Murrell DF etal. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22: 1302-1311.
18. Basset-Seguin N, Ibbotson SH, Emtestam L etal. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18: 547-553.
19. Rhodes LE, de Rie MA, Leifsdottir R etal. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-1136.
20. Berroeta L, Clark C, Dawe RS, Ibbotson SH, Fleming CJ. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 2007; 157: 401-403.
21. Wang I, Bendsoe N, Klinteberg CA etal. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-840.
22. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23: 1118-1126.
23. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-2269.
24. Telfer NR, Colver GB, Morton CA. British Association of D. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
25. Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536-544.
26. Braathen LR, Szeimies RM, Basset-Seguin N etal. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-143.
27. Lindberg-Larsen R, Solvsten H, Kragballe K. Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients. Acta Derm Venereol 2012; 92: 144-147.
28. Surrenti T, De Angelis L, Di Cesare A, Fargnoli MC, Peris K. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol 2007; 17: 412-415.
29. Haller JC, Cairnduff F, Slack G etal. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143: 1270-1275.
30. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 1999; 79: 204-206.
31. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998; 134: 248-249.
32. Schleier P, Berndt A, Kolossa S, Zenk W, Hyckel P, Schultze-Mosgau S. Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma. Photodiagnosis Photodyn Ther 2007; 4: 197-201.
33. Kuijpers DI, Thissen MR, Thissen CA, Neumann MH. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006; 5: 642-645.